Interface Biologics Inc. – Trademark Portfolio
Entity Type: 03
Interface Biologics Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 9 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ENDEXO and EPIDEL. The owner is based in Toronto, Ontario.
MaRS Centre, South Tower
101 College Street, Suite 300
Toronto, Ontario M5G1L7 , CA
Showing of trademarks Trademarks
Trademark Classifications
Interface Biologics Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Interface Biologics Inc. have?
Interface Biologics Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 7 abandoned, 2 cancelled.
What trademark classes does Interface Biologics Inc. file in?
Interface Biologics Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Interface Biologics Inc.'s most well-known trademarks?
Interface Biologics Inc.'s registered trademark portfolio includes well-known marks such as ENDEXO and EPIDEL. These are among 2 currently registered trademarks in the portfolio.
What is Interface Biologics Inc.'s trademark registration success rate?
Interface Biologics Inc. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.